GPT-5 is being used in an autonomous laboratory setting to improve cell-free protein synthesis, with some reports indicating a 40% improvement over current benchmarks. The technology has been used to conduct a large number of experiments, potentially optimizing protein production. The collaboration between OpenAI and Ginkgo Bioworks may have broader implications, including potential cost reductions and accelerated progress in certain fields.